Raymond James Financial Inc. Takes $2.28 Million Position in The Chemours Company (NYSE:CC)

Raymond James Financial Inc. bought a new stake in The Chemours Company (NYSE:CC - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 135,110 shares of the specialty chemicals company's stock, valued at approximately $2,283,000. Raymond James Financial Inc. owned approximately 0.09% of Chemours at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the stock. GAMMA Investing LLC grew its position in shares of Chemours by 99.7% in the 4th quarter. GAMMA Investing LLC now owns 1,532 shares of the specialty chemicals company's stock valued at $26,000 after buying an additional 765 shares during the last quarter. Quadrant Capital Group LLC boosted its holdings in Chemours by 100.4% in the fourth quarter. Quadrant Capital Group LLC now owns 2,234 shares of the specialty chemicals company's stock valued at $38,000 after acquiring an additional 1,119 shares during the last quarter. Aster Capital Management DIFC Ltd bought a new position in Chemours during the 4th quarter worth approximately $48,000. KBC Group NV boosted its stake in shares of Chemours by 38.2% in the 4th quarter. KBC Group NV now owns 6,176 shares of the specialty chemicals company's stock valued at $104,000 after purchasing an additional 1,708 shares during the last quarter. Finally, EMC Capital Management raised its stake in Chemours by 74.6% during the fourth quarter. EMC Capital Management now owns 9,534 shares of the specialty chemicals company's stock worth $161,000 after buying an additional 4,073 shares during the last quarter. Institutional investors own 76.26% of the company's stock.

Analysts Set New Price Targets

Several equities analysts have issued reports on CC shares. Barclays dropped their price target on Chemours from $19.00 to $16.00 and set an "equal weight" rating on the stock in a research note on Tuesday, April 1st. The Goldman Sachs Group cut their target price on shares of Chemours from $24.00 to $21.00 and set a "neutral" rating on the stock in a research note on Tuesday, January 7th. Mizuho set a $15.00 price target on shares of Chemours in a research note on Tuesday, April 15th. Truist Financial dropped their price objective on shares of Chemours from $27.00 to $22.00 and set a "buy" rating on the stock in a report on Monday, April 14th. Finally, BMO Capital Markets reduced their target price on Chemours from $34.00 to $27.00 and set an "outperform" rating for the company in a research note on Wednesday, February 19th. Four research analysts have rated the stock with a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average target price of $21.56.

Chemours Trading Up 2.2 %

NYSE CC traded up $0.27 during trading on Friday, hitting $12.47. 1,885,956 shares of the company's stock traded hands, compared to its average volume of 1,878,312. The stock has a fifty day moving average of $12.87 and a two-hundred day moving average of $16.79. The Chemours Company has a 12-month low of $9.33 and a 12-month high of $29.21. The firm has a market cap of $1.86 billion, a P/E ratio of 21.88 and a beta of 1.76. The company has a debt-to-equity ratio of 6.70, a current ratio of 1.68 and a quick ratio of 0.92.

Chemours (NYSE:CC - Get Free Report) last announced its quarterly earnings results on Tuesday, February 18th. The specialty chemicals company reported $0.11 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.10 by $0.01. Chemours had a net margin of 1.51% and a return on equity of 26.54%. The business had revenue of $1.36 billion for the quarter, compared to analyst estimates of $1.37 billion. As a group, sell-side analysts expect that The Chemours Company will post 2.03 EPS for the current year.

Chemours Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, March 14th. Investors of record on Friday, February 28th were issued a $0.25 dividend. This represents a $1.00 annualized dividend and a dividend yield of 8.02%. The ex-dividend date was Friday, February 28th. Chemours's payout ratio is currently 175.44%.

Chemours Company Profile

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.